Bulletin
Investor Alert

press release

June 9, 2022, 8:31 a.m. EDT

Thinking about buying stock in Bluejay Diagnostics, Sonnet BioTherapeutics, SeaChange International, Rekor Systems, or Aldeyra Therapeutics?

Jun 09, 2022 (PRNewswire via COMTEX) -- PR Newswire

NEW YORK, June 9, 2022

NEW YORK, June 9, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BJDX, SONN, SEAC, REKR, and ALDX.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

(note:You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-bluejay-diagnostics-sonnet-biotherapeutics-seachange-international-rekor-systems-or-aldeyra-therapeutics-301564967.html

SOURCE InvestorsObserver

COMTEX_408431416/2454/2022-06-09T08:30:30

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2022 PR Newswire. All rights reserved

Comtex

Partner Center

Link to MarketWatch's Slice.